Anchorage Capital Group, L.L.C. Roivant Sciences Ltd. Transaction History
Anchorage Capital Group, L.L.C.
- $239 Million
- Q2 2025
A detailed history of Anchorage Capital Group, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Anchorage Capital Group, L.L.C. holds 4,832,642 shares of ROIV stock, worth $78.1 Million. This represents 22.79% of its overall portfolio holdings.
Number of Shares
4,832,642
Previous 4,832,642
-0.0%
Holding current value
$78.1 Million
Previous $48.8 Million
11.69%
% of portfolio
22.79%
Previous 21.21%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$969 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$723 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$636 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$572 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$554 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.4B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...